Drugmakers have spent a record $342 billion on M&A in 2019
December 09, 2019 at 17:23 PM EST
A string of multibillion-dollar pharmaceutical deals announced over the last week call attention to a record-setting year in which drugmakers and biotechs have spent $342 billion snapping up smaller companies to bolster their pipelines.
